News
Dr. Harindu Wijesinghe is a medical specialist in Rheumatology and Rehabilitation, as well as in Sports Medicine. He ...
LAHORE: Under the dynamic leadership of CM Punjab Maryam Nawaz Sharif, Punjab will be free from dengue and other infectious ...
According to the Directorate General of Health Services (DGHS), in recent fatalities, one was reported in Chattogram Division ...
Punjab health minister Dr Balbir Singh emphasised that the health department is educating the public on preventive measures to mitigate the risks of vector-borne diseases and weather-related health co ...
Five more deaths were reported from dengue in 24 hours till Friday morning (13 June) – the highest number of deaths in a single day so far this year, raising the number of fatalities from the Aedes ...
1d
Clinical Trials Arena on MSNMSD begins Phase III trial of dengue vaccineThey will be randomised and given either a single dose of the vaccine or a placebo. More than 30 trial sites across dengue ...
Explore more
1d
United News of Bangladesh on MSNDengue: 5 die, 159 new cases reported in 24hrsFive deaths were reported from dengue in 24 hour till Friday morning, raising the number of fatalities from the mosquito-borne disease in Bangladesh 28 this year.
"During the period, 89 were hospitalised in Barishal, four in Chattogram, one in Rajshahi, three in Dhaka division, one in Dhaka north and 10 were admitted to different hospitals in Dhaka south," said ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the safety, immunogenicity and efficacy of a ...
2d
InvestorsHub on MSNMerck Launches Final-Stage Trial of Dengue Vaccine for ChildrenMerck & Co Inc (NYSE:MRK) has begun a Phase 3 clinical trial to test its experimental dengue vaccine in a pediatric ...
Aimed to enhance dengue awareness and bolster protection efforts, the UAD collaboration empowers communities to combat dengue through a multi-pronged approach: disease education, early action ...
2d
Stockhead on MSNIsland backs ISLA-101 dengue potential with top-line Phase 2a/b dataIsland Pharmaceuticals says Phase 2a/b top-line results advocate for continued clinical development of ISLA-101 to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results